Skip to main content
Clinical Trials/JPRN-UMIN000031128
JPRN-UMIN000031128
Not yet recruiting
未知

An evaluation and an examination of the cancer immunology for resectable non-small cell lung cancer - IOB-LC2

Tohoku Medical and Pharmaceutical University, Tohoku Medical and Pharmaceutical University Hospital0 sites20 target enrollmentFebruary 5, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients with resectable non-small cell lung cancer who are going to receive pulmonary resection
Sponsor
Tohoku Medical and Pharmaceutical University, Tohoku Medical and Pharmaceutical University Hospital
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 5, 2020
End Date
February 4, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tohoku Medical and Pharmaceutical University, Tohoku Medical and Pharmaceutical University Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients having an overlap cancer with activity Patients that an doctor judged to be inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials